GENINVO
LIVE

Serial Number

99338269

Owner

GenInvo, Inc.

Attorney

Matthew Saunders

Filing Date

Aug 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

GENINVO Trademark

Serial Number: 99338269 • Registration: 8193221

GENINVO is a trademark filed by GenInvo, Inc. on August 14, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

GenInvo, Inc. (5 trademarks)

Bloomington, IL 61701

Entity Type: 03

Trademark Details

Filing Date

August 14, 2025

Registration Date

March 31, 2026

Published for Opposition

February 10, 2026

Goods & Services

Providing temporary use of online non-downloadable software and software applications for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; providing temporary use of online non-downloadable software and software applications using artificial intelligence (AI) for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; Custom design of computer application software; Technical support services, namely, cloud managed services in the nature of remote infrastructure management services for migration, configuration, monitoring, and management of cloud computing IT systems and cloud databases; Providing quality control services in the fields of clinical research, clinical trials, and applications for drug approval; Providing independent review of clinical trial data for medical or scientific purposes

Business consulting services for pharmaceutical and life sciences companies in the fields of clinical research, clinical trials, and applications for drug approval; Business data analytics and business data management services in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for business purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 13, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 13, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 13, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 13, 2026 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 31, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 31, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 31, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 31, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 14, 2025 MAFR
NEW APPLICATION ENTERED
Aug 14, 2025 NWAP